Trial intelligence / Profile preview

Encapsulated Fecal Microbiota Transplantation for Functional Dyspepsia

TCTR20251112003Phase 3Recruiting

Sponsor
Thailand Science Research and Innovation
Start
Nov 2023
Modality
Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in functional dyspepsia (FD) comparing Encapsulated FMT with Placebo (2 arms). Started Nov 2023; status: recruiting.

02

Drugs

fecal microbiome transplant
03

Conditions

functional dyspepsia (FD)

Beyond the preview

Go deeper on TCTR20251112003.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20251112003.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call